La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Capitol Health Croissance future

Future contrôle des critères 4/6

Capitol Health is forecast to grow earnings and revenue by 37.8% and 6% per annum respectively. EPS is expected to grow by 37.6% per annum. Return on equity is forecast to be 11.1% in 3 years.

Informations clés

37.8%

Taux de croissance des bénéfices

37.6%

Taux de croissance du BPA

Healthcare croissance des bénéfices	17.0%
Taux de croissance des recettes	6.0%
Rendement futur des capitaux propres	11.1%
Couverture par les analystes	Good
Dernière mise à jour	06 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 05

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Feb 14

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Jan 19

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Dec 22

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Dec 01

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Aug 17

Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Jul 25

Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Jul 04

Prévisions de croissance des bénéfices et des revenus

ASX:CAJ - Estimations futures des analystes et données financières antérieures (AUD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
6/30/2027	276	N/A	N/A	47	1
6/30/2026	269	16	22	47	8
6/30/2025	254	13	19	42	8
6/30/2024	239	8	10	33	8
12/31/2023	229	6	12	36	N/A
9/30/2023	219	-3	16	37	N/A
6/30/2023	210	-11	21	38	N/A
3/31/2023	198	-12	19	33	N/A
12/31/2022	187	-12	16	28	N/A
9/30/2022	186	-1	18	30	N/A
6/30/2022	184	11	19	32	N/A
3/31/2022	186	12	22	34	N/A
12/31/2021	188	14	26	36	N/A
9/30/2021	183	13	29	39	N/A
6/30/2021	178	12	33	41	N/A
3/31/2021	168	8	33	43	N/A
12/31/2020	159	4	34	45	N/A
9/30/2020	156	3	28	40	N/A
6/30/2020	154	1	23	35	N/A
3/31/2020	156	8	18	30	N/A
12/31/2019	157	15	12	25	N/A
9/30/2019	153	20	8	22	N/A
6/30/2019	149	24	4	18	N/A
12/31/2018	137	-2	5	15	N/A
9/30/2018	128	-6	4	13	N/A
6/30/2018	119	-11	4	11	N/A
12/31/2017	110	2	7	15	N/A
9/30/2017	108	2	N/A	15	N/A
6/30/2017	107	2	N/A	15	N/A
12/31/2016	80	1	N/A	13	N/A
9/30/2016	92	2	N/A	13	N/A
6/30/2016	104	2	N/A	13	N/A
3/31/2016	148	-2	N/A	15	N/A
12/31/2015	139	1	N/A	13	N/A
9/30/2015	125	3	N/A	14	N/A
6/30/2015	110	4	N/A	16	N/A
3/31/2015	103	6	N/A	16	N/A
12/31/2014	95	9	N/A	16	N/A
9/30/2014	92	8	N/A	14	N/A
6/30/2014	90	7	N/A	12	N/A
3/31/2014	83	6	N/A	10	N/A
12/31/2013	77	5	N/A	7	N/A
9/30/2013	70	4	N/A	7	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: CAJ's forecast earnings growth (37.8% per year) is above the savings rate (2.4%).

Bénéfices vs marché: CAJ's earnings (37.8% per year) are forecast to grow faster than the Australian market (13.1% per year).

Croissance élevée des bénéfices: CAJ's earnings are expected to grow significantly over the next 3 years.

Chiffre d'affaires vs marché: CAJ's revenue (6% per year) is forecast to grow faster than the Australian market (5.4% per year).

Croissance élevée des revenus: CAJ's revenue (6% per year) is forecast to grow slower than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: CAJ's Return on Equity is forecast to be low in 3 years time (11.1%).

Capitol Health Croissance future

Future contrôle des critères 4/6

Informations clés

Mises à jour récentes de la croissance future

Price target decreased by 9.8% to AU$0.28

Price target decreased by 9.6% to AU$0.33

Price target increased to AU$0.43

Consensus EPS estimates fall by 12%

Analysts increase EPS estimates to AU$0.012

Price target raised to AU$0.36

Recent updates

Capitol Health Limited to Report Fiscal Year 2024 Results on Aug 22, 2024

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Calculating The Fair Value Of Capitol Health Limited (ASX:CAJ)

Now 21% undervalued after recent price drop

Now 21% undervalued

First half dividend of AU$0.005 announced

First half 2024 earnings released: EPS: AU$0.002 (vs AU$0.015 loss in 1H 2023)

New major risk - Financial position

Now 20% undervalued

Capitol Health Limited to Report First Half, 2024 Results on Feb 29, 2024

Capitol Health Limited Appoints Brendon Pentland as the Chief Financial Officer, Effective 1 April 2024

Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear

Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt

Now 21% undervalued

Now 21% undervalued after recent price drop

Capitol Health Limited Announces the Resignation of Craig Bremner as Chief Financial Officer

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased by 9.8% to AU$0.28

Capitol Health Limited, Annual General Meeting, Nov 15, 2023

Full year 2023 earnings: EPS misses analyst expectations

Capitol Health Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Price target decreased by 9.6% to AU$0.33

Capitol Health Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued

Now 21% undervalued

Capitol Health Limited (ASX:CAJ) completed the acquisition of Future Medical Imaging Group Pty Ltd.

Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?

Capitol Health Limited Declares Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Price target increased to AU$0.43

Capitol Health Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings: EPS misses analyst expectations

Capitol Health Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 October, 2022

Consensus EPS estimates fall by 12%

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Capitol Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 1, 2022

Capitol Health Limited to Report First Half, 2022 Results on Feb 24, 2022

Full year 2021 earnings released: EPS AU$0.012 (vs AU$0.001 in FY 2020)

Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly

Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Analysts increase EPS estimates to AU$0.012

First half 2021 earnings released: EPS AU$0.006 (vs AU$0.004 in 1H 2020)

Price target raised to AU$0.36

New 90-day high: AU$0.34

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Capitol Health Limited (ASX:CAJ) acquired Direct Radiology.

Capitol Health Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$0.28

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Price target raised to AU$0.31

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

New 90-day high: AU$0.27

Capitol Health Limited Appoints Craig Bremner as Chief Financial Officer, November 9, 2020

Capitol Health Limited Announces Resignation of Marcell Judkins as Chief Financial Officer

Price target raised to AU$0.27

Capitol Health Limited (ASX:CAJ) completed the acquisition of 90% stake in Fowler Simmons Radiology.

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Capitol Health Limited to Report Fiscal Year 2020 Results on Aug 26, 2020

Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Prévisions de croissance des bénéfices et des revenus

Prévisions de croissance des analystes

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres